Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022;12(7):2009-2013.
doi: 10.3233/JPD-223491.

Autopallidotomy: From Colloquial Term to Scientific Theory

Affiliations
Review

Autopallidotomy: From Colloquial Term to Scientific Theory

Stuart J McCarter et al. J Parkinsons Dis. 2022.

Abstract

Levodopa-induced dyskinesia (LID), a frequent complication of Parkinson's disease (PD), occurs in ∼30% of patients after five years' treatment with levodopa. In atypical parkinsonism, LID occurs less frequently than in PD. Lower frequency of LID in atypical parkinsonism has traditionally been attributed to lower amounts of levodopa used by these patients; however, recent studies have shown lower frequency of LID in atypical parkinsonism compared with PD when adjusting for levodopa dose. The mechanism of LID is complex but requires pulsatile levodopa stimulation, progressive presynaptic dopaminergic degeneration, and a relatively intact postsynaptic dopaminergic system. The globus pallidus internus (GPi), the main inhibitory nucleus of the basal ganglia, may play a major role in the development and treatment of LID. Surgical lesioning of the posteroventral GPi is directly antidyskinetic; animal models showing GPi-associated striatal neurons are directly responsible for the development of LID. However, other cortical areas, particularly the primary sensory and motor cortices may also play a role in LID. In some cases of atypical parkinsonism, particularly progressive supranuclear palsy and corticobasal degeneration, severe degeneration of the GPi, a so-called "autopallidotomy," may explain the absence of LID in these patients. In other atypical parkinsonisms, such as PD dementia and dementia with Lewy bodies, the lower incidence of LID may partly be attributed to more striatal degeneration but likely also relates to the degeneration of the motor cortex and resultant network dysfunction. Overall, atypical parkinsonism serves as a natural model that may ultimately reveal more effective therapies for LID.

Keywords: Dyskinesia; Parkinson’s disease; dementia; parkinsonism.

PubMed Disclaimer

Conflict of interest statement

SJM has no conflict of interest to report. RS receives funding from the National Institute on Aging, the National Institute of Neurological Disorders and Stroke, the Parkinson’s Disease Foundation, Inc., and an unrestricted grant from ACADIA Pharmaceuticals, Inc.

Figures

Fig. 1
Fig. 1
In the figure on the left, a lower Braak Stage is associated with less diffuse Lewy body accumulation and less aging changes; therefore autopallidotomy does not occur, whereas in more diffuse and higher Braak stage there are increased Lewy bodies and age-related changes leading to autopallidotomy.

References

    1. Turcano P, Mielke MM, Bower JH, Parisi JE, Cutsforth-Gregory JK, Ahlskog JE, Savica R (2018) Levodopa-induced dyskinesia in Parkinson disease: A population-based cohort study. Neurology 91, e2238–e2243. - PMC - PubMed
    1. Espay AJ, Morgante F, Merola A, Fasano A, Marsili L, Fox SH, Bezard E, Picconi B, Calabresi P, Lang AE (2018) Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts. Ann Neurol 84, 797–811. - PubMed
    1. Martini ML, Mocco J, Panov F (2019) Neurosurgical approaches to levodopa-induced dyskinesia. World Neurosurg 126, 376–382. - PubMed
    1. Turcano P, Stang CD, Bower JH, Ahlskog JE, Boeve BF, Mielke MM, Savica R (2020) Levodopa-induced dyskinesia in dementia with Lewy bodies and Parkinson disease with dementia. Neurol Clin Pract 10, 156–161. - PMC - PubMed
    1. Lang AE (2005) Treatment of progressive supranuclear palsy and corticobasal degeneration. Mov Disord 20 Suppl 12, S83–91. - PubMed